The sad reality is that when a doctor tells their patient that they have malignant pleural mesothelioma (MPM), they are also usually told that they will not live very long. While there are various treatment methods used by oncologists, they are often very invasive and even in the best cases will only prolong a patient’s life a relatively short period of time. They are often done at the expense of a patient’s already diminished quality of life.
There are a variety of reasons that there are so few effective means to treat malignant mesothelioma, but a lot of it has to do with a lack of research attributable to inadequate funding. This is because malignant mesothelioma is a relatively rare form of cancer. It is almost unheard of to occur without the patient being exposed to asbestos, and, even then, we generally see around 2,500 new cases each year in the United States. While this relative rarity is of no comfort to the victims and their families, the numbers are very small when compared to other forms of cancer. This means there is no profit in developing a treatment for mesothelioma for the big drug companies, so they do not spend a lot of money on developing a cure. Continue reading
Mesothelioma Lawyers Blog











